Trial intelligence / Profile preview

V158866 in Central Neuropathic Pain Following Spinal Cord Injury

NCT01748695Phase 2Completed

Sponsor
Brigham and Women's Hospital
Start
Jun 2013
Primary completion
Jul 2015
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of V158866 in neuropathic pain, sponsored by Brigham and Women's Hospital. Started Jun 2013; status: completed.

02

Drugs

V158866
03

Conditions

neuropathic pain

Beyond the preview

Go deeper on NCT01748695.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01748695.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call